期刊文献+

子宫内膜异位症生化标记物的临床意义 被引量:4

Clinical significance of biochemical markers in endometriosis
下载PDF
导出
摘要 子宫内膜异位症是一种妇科多发病,发病机制仍不清楚,临床上至今还缺乏用于诊断的有效生化标志物。子宫内膜异位症患者体内有许多生化分子的表达发生变化,其与子宫内膜异位症的发生、发展有关,如CA-125、CA19-9、抗子宫内膜抗体等,目前已经是内异症诊断的重要辅助手段。其它分子,如白细胞介素、黏附分子、肿瘤坏死因子、生长因子等在血清或腹腔液中的浓度也发生改变,研究这些变化与内异症的关系可以提示这些生化分子的临床应用价值,为内异症的诊断提供更简便、更易普及的血清学检测方法。 Endometriosis (EMs) is a common and frequent gynecopathy. Its pathogenesis is unclear till now. No effective biochemical markers that can be used to diagnose endometriosis are available in clinical work. Many researches showed that the expression of various biochemical molecules changes in patients with endometriosis. These molecules such as CA-125, CA19-9 and EMAb are associated with occurrence and development of EMs. Detection for them has become an auxiliary method in the diagnosis of EMs. Also the concentrations of some other molecules in serum or abdominal fluid such as interleukin, adhesion molecule, TNF, growth factor and so on change in the patients with endometriosis, which reveals the clinical value of these molecules by researching the relationship between these changes and EMS, so as to provide a more convenient and popular serologicaUy diagnosing method for EMs.
作者 胡芬 张炜
出处 《中国妇幼健康研究》 2006年第4期327-329,共3页 Chinese Journal of Woman and Child Health Research
关键词 子宫内膜异位症 血清标记物 腹腔液标记物 生化标记物 endometriosis serum marker peritoneal marker biochemical marker
  • 相关文献

参考文献14

  • 1Kuscu E,Gokmen O,Ozaksit G,et al.Serum CA 125 levels before,during and after treatment for endometriosis[J].International Journal of Gynecology &Obstetrics,2002,50(1995):269-273.
  • 2Kitawaki J,Ishihara H,Koshihara H,et al.Usefulness and limits of CA125 in diagnosis of endometriosis without associated ovarian endometriomas[J].Human Reproduction,2005,20(7):1999-2003.
  • 3Harada T,Kubota T,Aso T.Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis[J].Fertility and Sterility,2002,78(4):733-739.
  • 4Gagne D,Rivard M,Page M,et al.Development of a nonsurgical diagnosis tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA125 levels[J].Fertility and Sterility,2003,80(4):876-885.
  • 5Bedaiwy M A,Falcone T.Laboratory testing for endometriosis[J].Clinica Chimica Acta,2004,340(1-2):41-56.
  • 6Somigliana E,Vigano P,Tirelli A S,et al.Use of the concomitant serum dosage of CA125,CA19-9 and interleukine-6 to detect the presence of endometriosis:Results form a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions[J].Human Reproduction,2004,19(8):1871-1876.
  • 7Kurata H,Sasaki M,Kase H,et al.Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma[J].European Journal of Obstetrics Gynecology and Reproductive Biology,2002,105(1):75-76.
  • 8Janelle L,Yasemin S,Umit A K,et al.Regulation of interleukin-8 expression in human endometrial endothelial cells:a protein mechanism for the pathogenesis of endometriosis[J].Obstetrics and Gynecology,2005,90(3):1805-1811.
  • 9Slater M,Cooper M,Murphy C R.Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma[J].Acta Histochem,2006,108(1):3203-3210.
  • 10Hudelist G,Lass H,Keckstein J,et al.Interlukin-1[alpha] and tissue-lytic matric metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis[J].Human Reproduction,2005,20(6):1695-1701.

同被引文献23

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部